Results 91 to 100 of about 6,202 (205)

Radiosynthesis, in vitro and preliminary in vivo evaluation of the novel glutamine derived PET tracers [18F]fluorophenylglutamine and [18F]fluorobiphenylglutamine

, 2020
INTRODUCTION: Glucose has been deemed the driving force of tumor growth for decades. However, research has shown that several tumors metabolically shift towards glutaminolysis.
Baguet, Tristan, Beyzavi, M. Hassan, De Lombaerde, Stef, De Vos, Filip, Descamps, Benedicte, Donche, Sam, Goethals, Ingeborg, Hu, Jiyun, Lambe, Patricia, Pauwelyn, Glenn, Piron, Sarah, Vanhove, Christian, Verhoeven, Jeroen   +12 more
core   +1 more source

Implant-prosthetic therapy failure in smoker and nonsmoker patients [PDF]

, 2015
Introduction: Implant-prosthetic therapy has predictable success, and the complications are associated with a lot of factors. Smoking cigarettes is reason for different oral diseases, bone loss, loss of soft tissue and teeth, appearance of ...
Bajraktarova Valjakova, Emilija, Gigovski, Nikola, Korunoska Stevkovska, Vesna, Mijoska, Aneta, Popovska, Mirjana, Zlatanovska, Katerina   +5 more
core  

Automation of a Positron-emission Tomography (PET) Radiotracer Synthesis Protocol for Clinical Production. [PDF]

, 2018
The development of new positron-emission tomography (PET) tracers is enabling researchers and clinicians to image an increasingly wide array of biological targets and processes.
Collins, Jeffrey, Drake, Christopher, Schopf, Eric, Slavik, Roger, van Dam, R Michael, Waldmann, Christopher M   +5 more
core  

Types of scaffolds and their application in bone tissue engineering [PDF]

, 2015
Bone tissue engineering is founded on the conception of bone structure, bone mechanics and tissue creature as it aims to restore, maintain, or improve tissue functions that are defective or have been lost by different pathological conditions.
Bosnakovski, Darko, Volceva, Milena
core  

Toimintaohje Tc-99m-fosfonaatin käyttökuntoon saattamiseen radiofarmasiakaapissa [PDF]

, 2016
Radiolääkkeellä tarkoitetaan radioaktiivista lääkevalmistetta. Radiolääkeaineen määrän ollessa hyvin pieni, radiolääkkeellä ei ole farmakologista vaikutusta, siksi sen tehtävänä onkin vain kuljettaa radiolääke haluttuun kohteeseen.
Kekki, Heikki, Pirinen, Miikka, Ruuhela, Antti   +2 more
core  

Optimization of a GMP-compliant automated one-pot synthesis of Al[18F]F-NOTA-Ubiquicidin29 − 41 for bacterial infection imaging by PET/CT

EJNMMI Radiopharmacy and Chemistry
Background Bacterial infections and antimicrobial resistance constitute significant threats to global human health, resulting in millions of fatalities annually.
Anna Meyer, Thomas Ziegler, Jutta Moosbauer, Dirk Hellwig, Christian Fischer   +4 more
doaj   +1 more source

Editorial: ImmunoPET imaging in disease diagnosis and therapy assessment

Frontiers in Medicine, 2023
Francisca Mulero
doaj   +1 more source

Preclinical PET and SPECT Imaging in Small Animals: Technologies, Challenges and Translational Impact

Cells
Molecular imaging in preclinical research using PET and SPECT has become a key component of contemporary biomedicine, enabling noninvasive, quantitative, and longitudinal assessment of biological processes in vivo. Rapid technological progress, including
Magdalena Bruzgo-Grzybko, Izabela Suwda Kalita, Adam Jan Olichwier, Natalia Bielicka, Ewa Chabielska, Anna Gromotowicz-Poplawska   +5 more
doaj   +1 more source

Drug interactions involving therapeutic radiopharmaceuticals: a systematic review

EJNMMI Radiopharmacy and Chemistry
Background Drug interactions with diagnostic radiopharmaceuticals are well recognized, as they can modify biodistribution and lead to false or misleading diagnostic results.
Robin Gacon, Romane Chapuis, Luca Fabris-Davet, Nina Ranjit, Sylvain Goutelle, Laurent Bourguignon, Anthime Flaus, Claire Bolot, Elise Levigoureux, Matthieu Gallet, Sarah Chaib   +10 more
doaj   +1 more source

Co-57-based intercomparison of TLC scanners and dose calibrators for low-activity radiochemical purity assessment in radiopharmaceutical quality control. [PDF]

EJNMMI Radiopharm Chem
Straub M, Leresche M, Pilloud C, Hesselmann R, Stritt N, Cusnir R.   +5 more
europepmc   +1 more source